FHB
TEVA icon

First Hawaiian Bank’s Teva Pharmaceuticals TEVA Stock Holding History

First Hawaiian Bank’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-32,804
Closed -$723K – 680
2024
Q4 		$723K Buy
+32,804
New +$597K 0.02% 515
2013
Q3 		– Sell
-3,978
Closed -$156K – 464
2013
Q2 		$156K Buy
+3,978
New +$155K 0.03% 152

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

First Hawaiian Bank's TEVA Position: Q1 2025 in Review

First Hawaiian Bank sold out of Teva Pharmaceuticals (TEVA) in Q1 2025, closing a stake of 32,804 shares — an estimated $723K sold.

First Hawaiian Bank first reported a position in TEVA in Q2 2013 and held it in 2 quarters. The position peaked at $723K in Q4 2024. 560 funds tracked by Wall St. Rank hold TEVA as of Q1 2025.

  • First Hawaiian Bank reported no remaining Teva Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • First Hawaiian Bank sold 32,804 Teva Pharmaceuticals shares in Q1 2025, an estimated $723K.
  • First Hawaiian Bank first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 2 quarters.
  • First Hawaiian Bank's Teva Pharmaceuticals position peaked at $723K in Q4 2024.
  • 560 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2025.

Based on First Hawaiian Bank's 13F filing for Q1 2025, filed 3 Apr 2025.